23/10/2021

THAILAND DAILY

NEWSPAPER / MAGAZINE / PUBLISHER

covid-19-vaccine-for-kids:-pfizer-asks-us.-fda-for-emergency-approval

COVID-19 vaccine for kids: Pfizer asks U.S. FDA for emergency approval

Click to play video: 'Health Canada awaiting clinical trial data for Pfizer kids COVID-19 vaccine' Health Canada awaiting clinical trial data for Pfizer kids COVID-19 vaccine

WATCH: Health Canada awaiting clinical trial data for Pfizer kids COVID-19 vaccine.

Pfizer Inc. and BioNTech said on Thursday they had asked U.S. regulators to approve emergency use of their COVID-19 vaccine for children aged from five to 11, Pfizer said in a post on Twitter.

“We and @BioNTech_Group officially submitted our request to @US_FDA for Emergency Use Authorization (EUA) of our #COVID19 vaccine in children 5 to <12,” the company said.

“We’re committed to working with the FDA with the ultimate goal of helping protect children against this serious public health threat.”

UPDATE: We and @BioNTech_Group officially submitted our request to @US_FDA for Emergency Use Authorization (EUA) of our #COVID19 vaccine in children 5 to <12. pic.twitter.com/72Z2HXlkOx

— Pfizer Inc. (@pfizer) October 7, 2021

Story continues below advertisement

Pfizer has yet to make a full submission to Health Canada, but has sent in initial trial data to the Canadian regulator.

The company has previously said it hopes to make a full submission by mid-October.

(Reporting by Susan Heavey, Editing by Timothy Heritage)

— With files from Global News.

View link »

Comments

be the first to comment on this article

Leave a Reply

Your email address will not be published. Required fields are marked *

Take Me Top